“Buprenorphine patients remain disproportionately white and, while whites are more likely to have opioid addiction, the difference in prevalence alone is unlikely to explain this gap,” commented our Brendan Saloner
Quick Read
Our Brendan Saloner on Neonatal Abstinence Syndrome (NAS), a withdrawal condition that is the result of prenatal exposure to opioids, and the impact of community social stress on opioid use and NAS
Quick Read
Physicians Get Addicted TooApril 22, 2019 |
Lou Ortenzio was a trusted West Virginia doctor who got his patients—and himself—hooked on opioids. Now he’s trying to rescue his community from an epidemic he helped start
Quick Read
“When people get signed up for Medicaid, it increases the likelihood that they will seek all types of medical care including more visits to primary care doctors, and even when patients are not explicitly seeking care for opioid addiction, the greater contact with the health system creates more opportunities…” said lead study author Brendan Saloner
Quick Read
“It’s potentially a really big deal,” said Brendan Saloner, an assistant professor at the Johns Hopkins Berman Institute of Bioethics and Bloomberg School of Public Health , who has studied the opioid addiction crisis. Suboxone Film has “a really important role in the overall strategy of combating the overdose crisis,”
Quick Read
Here’s How One Small Town Beat The Opioid EpidemicMarch 1, 2019 |
Little Falls, Minnesota, didn’t do anything revolutionary. They just made a real effort — and spent real money — treating addiction as a disease, not a crime. With comments from our Brendan Saloner
Quick Read
“[The hospital] didn’t have any programs or anything to go to,” Angerer said. “It’s nobody’s fault but my own, but it definitely would have been helpful if I didn’t get brushed off.”
Quick Read
Alphabet’s Experimental Health Unit Takes On the Opioid EpidemicFebruary 6, 2019 |
Google parent company Alphabet Inc.’s experimental health-care unit Verily plans to partner with hospitals in Ohio, one of the states hardest-hit by the U.S. opioid epidemic, on a tech-heavy approach to treating people with substance-abuse disorders
Quick Read